MS Trust: The experimental nature of CCSVI

Release Date: November 19, 2010

Print

An article on England's Multiple Sclerosis Trust on the recent meeting of the European Committee for Treatment and Research in Multiple Sclerosis, the largest annual international conference devoted to basic and clinical research in MS, reports Robert Zivadinov, professor of neurology, presented research that showed a higher prevalence of CCSVI among people with secondary progressive MS, but "Our findings point against CCSVI having a primary causative role in the development of MS."

Media Contact Information

John DellaContrada
Vice President for University Communications
Tel: 716-645-4601 (mobile: 716-361-3006)
dellacon@buffalo.edu
Twitter: @UBNewsSource